# EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema

> **NCT00730301** · PHASE4 · UNKNOWN · sponsor: **LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology** · enrollment: 20 (estimated)

## Conditions studied

- Emphysema
- Chronic Obstructive Pulmonary Disease

## Interventions

- **PROCEDURE:** Bronchoscopic Lung Volume Reduction (BLVR)

## Key facts

- **NCT ID:** NCT00730301
- **Lead sponsor:** LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** 2008-09
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730301, "EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00730301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*